R&D
R&D Performance
Highly functional elastomers and plastomers
Developed elastic ethylene polymers using metallocene catalysts
- Developed and mass-produced the product using the proprietary metallocene catalyst technology for the first time in Korea in 2009
- The resulting product is a high value-added material that has both the elasticity of rubber and the processibility of plastic
Environment-friendly, super-absorbent resin for diapers (SAP)
Developed sustainable and super-absorbent resin of high quality using the photopolymerization technology
- Enhanced the sustainability of the product by reducing the amount of chemical residue through photopolymerization and crosslinking density control technology
- -Obtained high-quality product by enhancing its absorption properties through surface property modifying technology
High-durability, super-insulating Aerogel Blanket
Development of high-quality Aerogel blanket using supercritical drying method
- Independently developed mass production technology using supercritical drying method
- Achieved low dust dispersion and high-performance insulation by strengthening the 3D network structure with the sol-gel process and gel-casting technology
Ternary (+) electrode materials
Developed ternary (+) electrode materials for high-capacity and safe lithium-ion rechargeable batteries
- -Enhanced the capacity of lithium-ion rechargeable batteries and their performance at high temperatures by forming a stable structure of three elements: nickel, manganese, and cobalt
- -Minimized the volume change during charging and discharging to increase the lifespan of the battery and improve its safety
Highly Dispersible Bundle-Type CNT
Developed nanoscale carbon materials with optimal performance as conductive additives for secondary batteries
- Advanced the bundle type by dividing and adjusting the size of particles through support control technology
- Achieved excellent quality using fluidized bed reaction technology favorable for mass production
Zemiglo
Korea’s first new diabetes treatment drug
- Controls blood sugar levels by increasing the actions of incretin hormones that promote insulin secretion
- Fewer side effects such as low blood sugar and weight gain compared to other drugs
- Became the first new Korean drug to reach KRW 100 billion in sales in 2020
Eupolio
World’s first attenuated Sabin IPV to receive the prequalification status from the WHO
- Next-generation inactivated vaccine that has chemically removed pathogenicity using attenuated (weakened) viruses
- Enhanced stability compared to existing live vaccines
